Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Goldberg

Showing results (11-20 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Psychiatry|February 1, 2024
Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based AppraisalJoseph F Goldberg
The Journal of Clinical Psychiatry|March 27, 2024
Valproate and Weight Gain: A New Look at an Old ProblemJoseph F Goldberg
Focus (American Psychiatric Publishing)|February 13, 2020
Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level OutcomesJoseph F Goldberg
The Australian and New Zealand Journal of Psychiatry|April 18, 2012
Antidepressants: the scapegoat of poor outcome bipolar disorder?Joseph F Goldberg
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 13, 2011
Expanding the bipolar construct while preserving its diagnostic integrity: are we keeping the baby or the bathwater?Joseph F Goldberg
The Journal of Clinical Psychiatry|August 11, 2017
Do You Order Pharmacogenetic Testing? Why?Joseph F Goldberg
The Journal of Clinical Psychiatry|February 10, 2009
Whither the academic psychiatrist?Joseph F Goldberg
Journal of Clinical Psychology|April 10, 2007
What psychotherapists should know about pharmacotherapies for bipolar disorderJoseph F Goldberg
The Journal of Clinical Psychiatry|April 2, 2015
Mixed depression: a farewell to differential diagnosis?Joseph F Goldberg
The Journal of Clinical Psychiatry|April 10, 2020
Psychiatry's Niche Role in the COVID-19 PandemicJoseph F Goldberg
Pageof 18

Showing results (11-20 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Psychiatry|February 1, 2024
Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based AppraisalJoseph F Goldberg
The Journal of Clinical Psychiatry|March 27, 2024
Valproate and Weight Gain: A New Look at an Old ProblemJoseph F Goldberg
Focus (American Psychiatric Publishing)|February 13, 2020
Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level OutcomesJoseph F Goldberg
The Australian and New Zealand Journal of Psychiatry|April 18, 2012
Antidepressants: the scapegoat of poor outcome bipolar disorder?Joseph F Goldberg
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 13, 2011
Expanding the bipolar construct while preserving its diagnostic integrity: are we keeping the baby or the bathwater?Joseph F Goldberg
The Journal of Clinical Psychiatry|August 11, 2017
Do You Order Pharmacogenetic Testing? Why?Joseph F Goldberg
The Journal of Clinical Psychiatry|February 10, 2009
Whither the academic psychiatrist?Joseph F Goldberg
Journal of Clinical Psychology|April 10, 2007
What psychotherapists should know about pharmacotherapies for bipolar disorderJoseph F Goldberg
The Journal of Clinical Psychiatry|April 2, 2015
Mixed depression: a farewell to differential diagnosis?Joseph F Goldberg
The Journal of Clinical Psychiatry|April 10, 2020
Psychiatry's Niche Role in the COVID-19 PandemicJoseph F Goldberg
Pageof 18